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In order to reconsider guidelines in dentistry, it is
required to introduce new concepts of personalised
patient diagnosis and treatment plan [1]. Worldwide
dentists have to make a big cultural effort in changing
the actual “reactive” therapeutic point of view, belonging
to the last century, into a futuristic “predictive” one.
The futuristic “5 Ps” (Predictive, Preventive, Personalised
and Participatory Periodontology) focuses on the early
integrated diagnosis (genetic, microbiology, biomarkers
host- derived detection) and on the active role of the
patient in which networked patients will shift from being
mere passengers to responsible drivers of their health.
We intend to propose five diagnostic levels (High tech
diagnostic tools, Genetic susceptibility, Bacterial Infec-
tion, Host-response factors and tissues breakdown
derived products) to be evaluated with the intention to
obtain a clear picture of the vulnerability of the single
individual for periodontitis in order to organise patients
stratification in different categories of risk [2].
Five diagnostic levels are here proposed (High tech
diagnostic tools, Genetic susceptibility, Bacterial Infec-
tion, Host-response factors and tissues breakdown
derived products), in order to evaluate the vulnerability
of the single individual for periodontitis to organise
patients stratification in different categories of risk [3].
Lab-on-a-chip technology may soon become an impor-
tant part of efforts to improve worldwide periodontal
health in developed nations as well as in the under-
served communities, resource-poor areas and poor
countries. The use of LOCs devices for periodontal
inspection will allow patients to be screened for period-
ontal diseases in settings other than the periodontist
practice, such as at a general practitioners, general den-
tists or dental hygienists. Personalised therapy tailored
respect to the particular medical reality of the specific
stratified patient will be the ultimate target to be rea-
lised by “5Ps” approach. A long distance has to be cov-
ered to reach the above targets but the pathway has
already been clearly outlined. Lab-on-a-chip technology
may soon become an important part of efforts to
improve worldwide periodontal health [4]. In developed
nations, the most highly valued qualities for portable,
easy-to-use diagnostic tools include speed, sensitivity,
and specificity; while in the underserved communities,
resource-poor areas and poor countries the goal of
researchers is to create micro fluidic chips that will allow
healthcare providers in poorly equipped hospitals. The use
of LOCs devices for periodontal inspection will involve
less education than current diagnostic procedures and
allow patients to be screened for periodontal disease in
settings other than the periodontist practice, such as at a
general practitioners, general dentists or dental hygienists.
All these benefits make the Lab-on-a-chip technology
ideal for Predictive, Preventive, Personalised and Parteci-
patory Periodontology. “The 5Ps” represent the future of
our profession. Personalised therapy tailored respect to the
particular medical reality of the specific stratified patient
will be the ultimate target to be realised by “5Ps”
approach. A long distance has to be covered to reach the
above targets but the pathway has already been clearly
outlined: it is “Time for new guidelines in advanced health-
care” in dentistry too [5].
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5Ps flow-chart. Five levels characterise a futuristic
approach for periodontal diagnosis. The first level is repre-
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(LOC) and cone beam computed tomography (CBCT). In
the next future LOC will be able to give us genetic, micro-
biological and host derived information in real time.
Co-factors (e.g. diabetes, osteoporosis etc.) will be detected
by the use of dedicated high-tech chair side diagnostic
tools. Moreover, a detailed bone tissue morphology is
revealed by low radiation digital computed tomography
which offers a digital volume composed of three dimen-
sional voxels that can then be manipulated with specia-
lised software. The second level will provide useful
information about genetic susceptibility of the single
patient, while the third level will give us the presence of
causative bacterial factors in dental plaque. Finally, host
derived biomarkers (host response factors and factors
derived from periodontal tissue breakdown) will be chair-
side detected in order to early intercept periodontal
destruction.
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